Drug Type CAR-T |
Synonyms CeCAR T, CeCAR-T |
Target |
Action modulators |
Mechanism CEACAM1 modulators(Carcinoembryonic antigen related cell adhesion molecule 1 modulators) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colorectal Cancer | Preclinical | United States | 22 Mar 2023 | |
| Pancreatic Cancer | Preclinical | United States | 22 Mar 2023 |





